AstraZeneca unveils $37bn US investment plan amid tariff threats
BY JENNIFER EZIMAKOR British-based drug maker AstraZeneca has announced plans to invest $50 billion in the United States over the next five years amid the… Read More »AstraZeneca unveils $37bn US investment plan amid tariff threats











